Effects of beta-naphthoflavone on the cytochrome P450 system, and phase IIenzymes in gilthead seabream (Sparus aurata)

Citation
C. Pretti et al., Effects of beta-naphthoflavone on the cytochrome P450 system, and phase IIenzymes in gilthead seabream (Sparus aurata), COMP BIOC C, 130(1), 2001, pp. 133-144
Citations number
53
Categorie Soggetti
Pharmacology & Toxicology
Journal title
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
ISSN journal
15320456 → ACNP
Volume
130
Issue
1
Year of publication
2001
Pages
133 - 144
Database
ISI
SICI code
1532-0456(200109)130:1<133:EOBOTC>2.0.ZU;2-Z
Abstract
The effect of P-naphthoflavone (P-NF) on several catalytic activities of cy tochrome P450 (CYP) and phase II enzymes putatively controlled by [Ah]-rece ptor activation in the liver, heart and kidney of gilthead seabream, was in vestigated. In the liver, P-NF treatment [intraperitoneal injection (i.p.) 50 mg/kg] resulted in an increase of CYP content, immunoreactive CYP IA and methoxyresorufin-O-demethylase (MEROD), pentoxyresorufin O-depentylase (PR OD) and ethoxyresorufin-O-deethylase (EROD) activities. However, beta -NF h ad no effect on any of the hepatic phase II enzymes examined (benzaldehyde dehydrogenase, propionaldehyde dehydrogenase, glutathione S-transferase, UD P-glucuronyl-transferase, DT-diaphorase). Single i.p. injection of 10 mg/kg beta -NF showed a maximal induction of CYP 1A-like protein and EROD activi ty after 3-7 days. CYP 1A and EROD returned to control levels 18-days post- treatment. beta -NF injection also caused a rapid increase of a single band size of mRNA recognized by a CYP 1A1 cDNA fragment from sea bass (Dicentra rchus labrax). Expression of mRNA preceded the increase of EROD activity an d declined rapidly by 96 h. Dose-response experiments demonstrated that ERO D was significantly enhanced in liver by a single injection of 0.3 mg/kg be ta -NF and was the most sensitive measurement for CYP IA-like induction. P- NF treatments also increased the expression of CYP IA-like protein, mRNA an d EROD, but not MEROD and PROD activities in heart and kidney, (C) 2001 Pub lished by Elsevier Science Inc.